A Postmarketing Noninterventional Cohort Study of the Safety of Live Attenuated Influenza Vaccine (LAIV) in Subjects 2 Through 17 Years of Age (Flu vaccine feedback study) First published 09/10/2014 Last updated 17/09/2025 EU PAS number:EUPAS7626 Study Finalised